A detailed history of Strs Ohio transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Strs Ohio holds 18,600 shares of HRMY stock, worth $613,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,600
Previous 20,900 11.0%
Holding current value
$613,800
Previous $630,000 17.94%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$30.0 - $39.95 $69,000 - $91,885
-2,300 Reduced 11.0%
18,600 $743,000
Q1 2024

May 13, 2024

BUY
$29.93 - $35.06 $625,537 - $732,754
20,900 New
20,900 $701,000
Q4 2022

Jan 26, 2023

BUY
$45.4 - $60.91 $254,240 - $341,096
5,600 New
5,600 $308,000
Q4 2021

Jan 24, 2022

SELL
$34.09 - $43.91 $37,499 - $48,300
-1,100 Closed
0 $0
Q3 2021

Oct 22, 2021

SELL
$25.68 - $38.61 $10,272 - $15,444
-400 Reduced 26.67%
1,100 $42,000
Q4 2020

Jan 25, 2021

BUY
$31.74 - $51.34 $47,610 - $77,010
1,500 New
1,500 $54,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.95B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.